Most Popular

Piper Jaffray Reiterates Overweight on GW Pharmaceuticals PLC- ADR (GWPH) Following Positive Results In Small Schizophrenia Trial

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) received another set of praises from analysts at Piper Jaffray in a research report released today. The research team, …

Under Armour Inc (UA) Named No. 1 Fitness App Platform in Piper Jaffray’s Women Survey

Piper Jaffray analyst Erinn Murphy came out today with a few insights on Under Armour Inc (NYSE:UA), after conducting a women’s survey where Piper Jaffray team surveyed …

Incyte Corporation (INCY): Bullish Option’s Positioning Supports Upside On Gilead Sciences, Inc. (GILD) M&A Thesis

After the market close on September 11th, Gilead Sciences, Inc. (NASDAQ:GILD) announced that it had raised $9.

Canaccord Reiterates Buy on Under Armour Inc (UA) Ahead of Investor Day

In a research report released Monday, Canaccord analyst Camilo Lyon reiterated a Buy rating on shares of Under Armour Inc (NYSE:UA) with a price …

Canaccord’s Best Trade Idea: Pacira Pharmaceuticals Inc (PCRX)

Canaccord analyst Corey Davis weighed in today with a favorable report on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), reiterating a Buy rating and a price …

Monday’s Morning Insights: Alibaba Group Holding Ltd (BABA), Nokia Corporation (NOK), Aquinox Pharmaceuticals Inc (AQXP)

Alibaba Group Holding Ltd (NYSE:BABA) shares slipped -3.11% to $62.

Company Update (NYSE:NOK): Nokia Corporation Receives Clearance From the Committee on Foreign Investment in the US for the Proposed Acquisition of Alcatel-Lucent

Nokia Corporation (ADR) (NYSE:NOK) announced that it has obtained clearance from the Committee on Foreign Investment in the United States (“CFIUS”) for its …

ZS Pharma Inc (ZSPH) Price Target Lifted at William Blair on Potential Acquisition

In a research report released today, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of ZS Pharma Inc (NASDAQ:ZSPH), while raising the …

Roth Capital Reiterates Buy on Cytori Therapeutics Inc ׁׁ(CYTX) Following Publication of Scleradec-I Data in Rheumatology

Roth Capital’s healthcare analyst Joseph Pantginis weighed in today with a few insights on Cytori Therapeutics Inc (NASDAQ:CYTX), after the company announced mature data and publication in …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts